📰 Single Dose Vials News
Single Dose Vials News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Single Dose Vials. Real-time updates on events, politics, business and more.
June 12, 2023
Caplin Steriles Ltd, a Subsidiary company of Caplin Point Laboratories Ltd, has been granted final approval from the United States Food and Drug Administration for its ANDA Cisatracurium Besylate Injection USP.
May 27, 2023
Aurobindo Pharma Ltds wholly owned subsidiary company, Eugia Pharma Specialties Ltd, has received a final approval from the USFDA to manufacture and market Carboprost Tromethamine Injection USP 250 mcg/mL, Single-Dose Vials.
February 9, 2023
Lupin Ltd has received approval from the U.S. FDA for its ANDA for Glycopyrrolate Injection USP, a generic equivalent of Robinul® Injection, 0.2 mg/mL of Hikma Pharmaceuticals USA Inc. This is the first approval from its Nagpur injectable facility.
February 9, 2023
Lupin Limited today announced that it has received approval from the United States Food and Drug Administration (U.S.FDA) for its abbreviated new drug application for Glycopyrrolate Injection USP, via an exchange filing.
January 11, 2023
Latin America Blow Fill Seal Technology Industry Trends, Demand, Growth, Value & Analysis Report by Zion Market Research

January 10, 2023
/PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce it has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL)...
January 10, 2023
Glenmark Pharmaceuticals Inc., USA has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) SingleDose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials, the generic version of Bumex® Injection.
November 1, 2022
Alembic Pharmaceuticals Ltd today announced that it has received final approval from the US Food & Drug Administration for its Abbreviated New Drug Application for Glycopyrrolate Injection.
May 26, 2022
This is the 139th ANDA (including 8 tentative approvals received) out of Eugia Pharma Specialty Group (EPSG) facilities, manufacturing both oral and sterile specialty products.
February 25, 2021
1Department of Biomedical Informatics, Vagelos College of Physicians and Surgeons, Columbia University in the City of New York 2Public Health Sciences and Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Seattle, Washington 3Healthcare Quality and Policy, Hutchinson Institute for Cancer Outcomes Research, Seattle, Washington 4Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine, Washington, DC JAMA. Published online February 25...